//
The Gastroesophageal Malignancies Investigator Network Initiative (GEMINI), funded by the Torrey Coast Foundation, supports high-risk, high-reward preclinical research and Phase 1 investigator-initiated trials for gastric and esophageal cancers. The program emphasizes translational research that can move findings from the lab into clinical application, often supporting unconventional approaches or new investigators who may have difficulty securing funding from other sources.
Torrey Coast Foundation is a private corporation based in SAN DIEGO, CA. The foundation received its IRS ruling in 2021. The principal officer is % Alan Braynin. It holds total assets of $317.1M. Annual income is reported at $228.6M. The foundation operates in the area of philanthropy & grantmaking. According to available records, Torrey Coast Foundation has made 51 grants totaling $19.8M, with a median grant of $175K. Annual giving has decreased from $13.3M in 2022 to $6.5M in 2023. Individual grants have ranged from $2K to $2.5M, with an average award of $388K. The foundation has supported 29 unique organizations. The foundation primarily supports organizations in California, New York, Massachusetts, which account for 63% of all grants. Grantmaking reaches organizations across 10 states. Contributions to this foundation are tax-deductible.
Torrey Coast Foundation primarily funds organizations in the area of philanthropy & grantmaking. Based on available records, the foundation has funded 51 grants. Its grantmaking reaches organizations primarily in CA, NY, MA.
Torrey Coast Foundation has distributed a total of $19.8M across 51 grants. The median grant size is $175K, with an average of $388K. Individual grants have ranged from $2K to $2.5M.
The application deadline is NO SUBMISSION DEADLINES.. RESTRICTED TO PRECLINICAL RESEARCH AND PHASE 1 TRIALS TREATING GASTROESOPHAGEAL CANCER.
Torrey Coast Foundation is headquartered in SAN DIEGO, CA. While based in CA, the foundation distributes grants to organizations across 10 states.
| Name | Title | Compensation | Benefits | Total |
|---|---|---|---|---|
| Alan Braynin | PRESIDENT | $0 | $0 | $0 |
Total Giving
$5.7M
Total Assets
$312.1M
Fair Market Value
$312.1M
Net Worth
$304.8M
Grants Paid
$4.4M
Contributions
$0
Net Investment Income
$10.9M
Distribution Amount
$14.9M
Total Grants
51
Total Giving
$19.8M
Average Grant
$388K
Median Grant
$175K
Unique Recipients
29
Most Common Grant
$100K
of 2023 grantees were first-time recipients
| Recipient | Location | Amount | Year |
|---|---|---|---|
| Columbia UniversitySCIENTIFIC RESEARCH | New York, NY | $500K | 2023 |
| The Entertainment Industry FoundationSCIENTIFIC RESEARCH | Los Angeles, CA | $2.5M | 2023 |
| Broad Institute GeminiSCIENTIFIC RESEARCH | Cambridge, MA | $605K | 2023 |
| Ucsd FoundationMEDICAL RESEARCH | La Jolla, CA | $600K | 2023 |
| The Degregorio Family FoundationMEDICAL RESEARCH | Pleasantville, NY |
| $438K |
| 2023 |
| Stand Up To CancerSCIENTIFIC RESEARCH | Los Angeles, CA | $200K | 2023 |
| Dana - Farber Cancer Gemini InstituteSCIENTIFIC RESEARCH | Boston, MA | $188K | 2023 |
| La Jolla Institute ImmunologySCIENTIFIC RESEARCH | La Jolla, CA | $175K | 2023 |
| Broad InstituteSCIENTIFIC RESEARCH | Cambridge, MA | $159K | 2023 |
| Cornell University The Joan & Sandford Weil Medical CollegeSCIENTIFIC RESEARCH | New York, NY | $151K | 2023 |
| The University Of Texas Md Anderson Cancer CenterSCIENTIFIC RESEARCH | Houston, TX | $150K | 2023 |
| HiasMEDICAL SUPPORT | Silver Spring, MD | $100K | 2023 |
| Cancer Researach InstituteMEDICAL RESEARCH | New York, NY | $100K | 2023 |
| Firework Foundationepic EntertainmentEDUCATIONAL SUPPORT | North Stillwater, MN | $100K | 2023 |
| Mit GeminiSCIENTIFIC RESEARCH | Cambridge, MA | $85K | 2023 |
| University Of Pennsylvania School Of MedicineSCIENTIFIC RESEARCH | Philadelphia, PA | $55K | 2023 |
| Medicins Sans FrontieresMEDICAL RESEARCH | New York, NY | $25K | 2023 |
| Int Committee Of The Red CrossMEDICAL SUPPORT | Geneva | $25K | 2023 |
| Uc San Diego FoundationINSTITUTE FOR NETWORK MEDICINE FOR A STUDY ENTITLED "RAPID TRANSLATION OF NOVEL IMMUNE CELL-TARGETED THERAPEUTICS IN ESOPHAGEAL AND GASTROESOPHAGEAL CANCERS", INSTITUTE FOR NETWORK MEDICINE FOR RESEARCH OF THE AREA OF GASTRIC CANCER, AND MOORES CANCER CENTER IMMUNOTHERAPY INNOVATION FUND. | La Jolla, CA | $1.3M | 2022 |
| Cornell University - The Joan And Sanford I Weill Medical CollegeTO PROMOTE AND ENHANCE THE WORK OF THE MEDICAL COLLEGE THROUGH THE SUPPORT OF RESEARCH TO GENERATE INFORMATION ON THE MECHANISMS OF "DIFFUSE" MESENCHYMAL TYPE OF GASTRIC CANCER AND TO PROMOTE AND ENHANCE THE WORK OF THE MEDICAL COLLEGE THROUGH THE SUPPORT OF RESEARCH IN IDENTIFYING AND TESTING EVIDENCE-BASED TARGETED THERAPEUTIC STRATEGIES IN GASTRIC CANCER: TARGETING TGF AND THE IMMUNE MICROENVIRONMENT. | New York, NY | $575K | 2022 |
| The Broad Institute IncFOR THE PROJECT, ADAPTING 3D CANCER ORGANOIDS INTO MONOLAYER CELL LINES TO EXPAND MODEL UTILIZATION AND FOR SCREENING COMPOUNDS USING THE PRISM SCREENING PLATFORM. | Pasadena, CA | $513K | 2022 |
| Memorial Sloan-Kettering Cancer CenterTO ORGANIZE RESEARCH IN ESOPHAGOGASTRIC CANCER UNDER THE DIRECTION OF DRS. YELENA JANJIGIAN AND KARUNA GANESH. | New York, NY | $396K | 2022 |
| Insititue Of Molecular Cell BiologyFOR GRANT PROPOSAL "EVALUATING GASTRIC CANCER THERAPEUTICS IN OUR CLDN18-ATK GENETICALLY ENGINEERED MOUSE MODEL OF GASTRIC CANCER". | Immunos | $247K | 2022 |
| University Of Texas Md Anderson Cancer Center"PERSONALIZED THERAPY FOR PATIENTS WITH ARID1A DEFICIT GASTRIC ADENOCARCINOMA (GAC)". | Houston, TX | $200K | 2022 |
| University Of UtahTO DEVELOP AND TEST NOVEL THERAPEUTICS FOR GASTRIC CANCER | Salt Lake City, UT | $150K | 2022 |
| Massachusettes General HospitalTO SUPPORT RSEARCH INCLUDING, BUT NOT LIMITED TO, EX-VIVO SENSITIVITY TESTING, BIOSENSOR EFFORTS, AND IDENTIFICATION OF DRUG AGENTS TO GENERATE CLINICAL TRIAL PILOT DATA IN REGARDS TO THE TREATMENTS OF ESOPHAGOGASTRIC CANCER | Boston, MA | $101K | 2022 |
| Hias IncTO SUPPORT UKRANIAN REFUGEES SEEKING SAFETY IN JEWISH COMMUNITIES IN EUROPE. | Silver Spring, MD | $100K | 2022 |
| Emory University School Of MedicineFOR GRANT PROPOSAL" ADENOSQUAMOUS CARCINOMAS OF THE ESOPHAGUS: UNIQUE BIOLOGICAL AND THERAPEUTIC INSIGHTS FROM A RARE CANCER". | Atlanta, GA | $77K | 2022 |
| Case Western Reserve UniversityCOLLABORATION WITH THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER AND COLUMBIA UNIVERSITY'S GI ONCOLOGY TEAMS. | Cleveland, OH | $46K | 2022 |
© 2026 Granted AI